Join thousands of book lovers
Sign up to our newsletter and receive discounts and inspiration for your next reading experience.
By signing up, you agree to our Privacy Policy.You can, at any time, unsubscribe from our newsletters.
This second edition features the latest data for lipids, hypertension and overall risk reduction plus a new chapter on incretins, amylin analogues and DPP-IV inhibitors. It includes an expanded section on lipid disorders in the diabetic patient.
Sign up to our newsletter and receive discounts and inspiration for your next reading experience.
By signing up, you agree to our Privacy Policy.